Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × OTHER × Pneumonia × Clear all

Phase

Status

Completed 23 Recruiting 9 Unknown 7 Not yet recruiting 5 Terminated 3 Withdrawn 1 Suspended 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 26 Breast Neoplasms 24 Prostatic Neoplasms 21 Colorectal Neoplasms 19 Lung Neoplasms 11 Brain Neoplasms 10 Stomach Neoplasms 9 Glioblastoma 9 Leukemia, Myeloid, Acute 8 Carcinoma, Non-Small-Cell Lung 8 Pancreatic Neoplasms 7 Ovarian Neoplasms 7 Glioma 7 Rectal Neoplasms 6 Multiple Myeloma 6 Melanoma 6 Head and Neck Neoplasms 6 Carcinoma, Hepatocellular 6 Triple Negative Breast Neoplasms 5 Neoplasm Metastasis 5 Lymphoma 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Polycystic Ovary Syndrome 4 Myelodysplastic Syndromes 4 Esophageal Neoplasms 4 Depression 4 Carcinoma, Renal Cell 4 Uterine Cervical Neoplasms 3 Small Cell Lung Carcinoma 3 Pain 3

Interventions

Prednisone 1 Clinical Protocols 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04036721 2023-02-23

PROS-CONS

National Institute for Tuberculosis and Lung Diseases, Poland

Phase 4 Suspended

Lung Neoplasms, Pneumonia, Lung Diseases, Interstitial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡